Clinical trials
Terminated Carcinoma, Hepatocellular trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 2 |
| Abbott | 1 |
| Bristol-Myers Squibb | 1 |
| Incyte Corporation | 1 |
| Lahey Clinic | 1 |
| Meridian Bioscience, Inc. | 1 |
| NCIC Clinical Trials Group | 1 |
| Ocellaris Pharma, Inc. | 1 |
| Ontario Clinical Oncology Group (OCOG) | 1 |
| Progen Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 12 |
| Neoplasms | 4 |
| Carcinoma, Renal Cell | 3 |
| Liver Neoplasms | 3 |
| Carcinoma, Merkel Cell | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Transitional Cell | 2 |
| Colorectal Neoplasms | 2 |
| Melanoma | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.